Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study.

Groenland SL, van Eerden RAG, Verheijen RB, Koolen SLW, Moes DJAR, Desar IME, Reyners AKL, Gelderblom HJ, van Erp NP, Mathijssen RHJ, Huitema ADR, Steeghs N.

Ther Drug Monit. 2019 Oct;41(5):561-567. doi: 10.1097/FTD.0000000000000654.

PMID:
31568233
2.

Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas.

Vlenterie M, Oyen WJ, Steeghs N, Desar IME, Verheijen RB, Koenen AM, Grootjans W, DE Geus-Oei LF, VAN Erp NP, VAN DER Graaf WT.

Anticancer Res. 2019 Mar;39(3):1309-1316. doi: 10.21873/anticanres.13243.

PMID:
30842163
3.

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies.

de Jonge MJA, Steeghs N, Lolkema MP, Hotte SJ, Hirte HW, van der Biessen DAJ, Abdul Razak AR, De Vos FYFL, Verheijen RB, Schnell D, Pronk LC, Jansen M, Siu LL.

Target Oncol. 2019 Feb;14(1):43-55. doi: 10.1007/s11523-018-00617-1.

4.

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520.

Verheijen RB, van der Biessen DAJ, Hotte SJ, Siu LL, Spreafico A, de Jonge MJA, Pronk LC, De Vos FYFL, Schnell D, Hirte HW, Steeghs N, Lolkema MP.

Target Oncol. 2019 Feb;14(1):67-74. doi: 10.1007/s11523-018-00618-0.

5.

Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling.

Verheijen RB, Thijssen B, Atrafi F, Schellens JHM, Rosing H, de Vries N, Beijnen JH, Mathijssen RHJ, Steeghs N, Huitema ADR.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 1;1104:234-239. doi: 10.1016/j.jchromb.2018.11.030. Epub 2018 Nov 30.

PMID:
30530116
6.

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.

Vergote I, Coens C, Nankivell M, Kristensen GB, Parmar MKB, Ehlen T, Jayson GC, Johnson N, Swart AM, Verheijen R, McCluggage WG, Perren T, Panici PB, Kenter G, Casado A, Mendiola C, Stuart G, Reed NS, Kehoe S; EORTC; MRC CHORUS study investigators.

Lancet Oncol. 2018 Dec;19(12):1680-1687. doi: 10.1016/S1470-2045(18)30566-7. Epub 2018 Nov 6. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

PMID:
30413383
7.

Proton MRS of cervical cancer at 7 T.

Arteaga de Castro CS, Hoogendam JP, van Kalleveen IML, Raaijmakers AJE, Zweemer RP, Verheijen RHM, Luijten PR, Veldhuis WB, Klomp DWJ.

NMR Biomed. 2019 Jan;32(1):e4015. doi: 10.1002/nbm.4015. Epub 2018 Oct 30.

8.

Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology.

Groenland SL, van Nuland M, Verheijen RB, Schellens JHM, Beijnen JH, Huitema ADR, Steeghs N.

Clin Pharmacokinet. 2019 Mar;58(3):299-308. doi: 10.1007/s40262-018-0683-0. Review.

PMID:
29862467
9.

The Society of European Robotic Gynaecological Surgery (SERGS) Pilot Curriculum for robot-assisted gynaecological surgery: authors' reply to a letter to the editor.

Rusch P, Verheijen RHM.

Arch Gynecol Obstet. 2018 Jun;297(6):1597. doi: 10.1007/s00404-018-4757-x. Epub 2018 Mar 21. No abstract available.

PMID:
29564529
10.

Fast and Straightforward Method for the Quantification of Pazopanib in Human Plasma Using LC-MS/MS.

Verheijen RB, Thijssen B, Rosing H, Schellens JHM, Nan L, Venekamp N, Beijnen JH, Steeghs N, Huitema ADR.

Ther Drug Monit. 2018 Apr;40(2):230-236. doi: 10.1097/FTD.0000000000000479.

PMID:
29256969
11.

The Society of European Robotic Gynaecological Surgery (SERGS) Pilot Curriculum for robot assisted gynecological surgery.

Rusch P, Kimmig R, Lecuru F, Persson J, Ponce J, Degueldre M, Verheijen R.

Arch Gynecol Obstet. 2018 Feb;297(2):415-420. doi: 10.1007/s00404-017-4612-5. Epub 2017 Dec 13.

12.

Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood-Brain Barrier Using Elacridar and 11C-Erlotinib PET.

Verheijen RB, Yaqub M, Sawicki E, van Tellingen O, Lammertsma AA, Nuijen B, Schellens JHM, Beijnen JH, Huitema ADR, Hendrikse NH, Steeghs N.

J Nucl Med. 2018 Jun;59(6):973-979. doi: 10.2967/jnumed.117.195800. Epub 2017 Nov 24.

13.

Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.

Verheijen RB, Swart LE, Beijnen JH, Schellens JHM, Huitema ADR, Steeghs N.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1171-1178. doi: 10.1007/s00280-017-3463-x. Epub 2017 Oct 19.

14.

Is there an increased risk of cervical neoplasia in atopic dermatitis patients treated with oral immunosuppressive drugs?

Garritsen FM, Verheijen RHM, Gerestein CG, van Zuilen AD, Oosterhaven JAF, van Dijk M, Bruijnzeel-Koomen CAF, Schuttelaar ML, de Bruin-Weller MS.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):271-275. doi: 10.1111/jdv.14593. Epub 2017 Oct 10.

PMID:
28925576
15.

Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial.

Verheijen RB, Atrafi F, Schellens JHM, Beijnen JH, Huitema ADR, Mathijssen RHJ, Steeghs N.

Clin Pharmacokinet. 2018 May;57(5):637-644. doi: 10.1007/s40262-017-0582-9.

16.

Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.

Verheijen RB, Yu H, Schellens JHM, Beijnen JH, Steeghs N, Huitema ADR.

Clin Pharmacol Ther. 2017 Nov;102(5):765-776. doi: 10.1002/cpt.787. Epub 2017 Sep 7. Review.

17.

Boosting the SNR by adding a receive-only endorectal monopole to an external antenna array for high-resolution, T2 -weighted imaging of early-stage cervical cancer with 7-T MRI.

van Kalleveen IML, Hoogendam JP, Raaijmakers AJE, Visser F, Arteaga de Castro CS, Verheijen RHM, Luijten PR, Zweemer RP, Veldhuis WB, Klomp DWJ.

NMR Biomed. 2017 Sep;30(9). doi: 10.1002/nbm.3750. Epub 2017 Jun 2.

PMID:
28574604
18.

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing.

Verheijen RB, Beijnen JH, Schellens JHM, Huitema ADR, Steeghs N.

Clin Pharmacokinet. 2017 Sep;56(9):987-997. doi: 10.1007/s40262-017-0510-z. Review.

19.

Locally advanced cervix cancer: staging by scan or by surgery?

Becker JH, Verheijen R.

BJOG. 2017 Jun;124(7):1096. doi: 10.1111/1471-0528.14596. Epub 2017 Mar 16. No abstract available.

20.

Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees.

Gan C, Bossart M, Piek J, Halaska M, Haidopoulos D, Zapardiel I, Grabowski JP, Kesic V, Kimmig R, Cibula D, Lambaudie E, Verheijen R, Manchanda R.

Int J Gynecol Cancer. 2017 Feb;27(2):375-381. doi: 10.1097/IGC.0000000000000879.

PMID:
28114237
21.

Individualized Pazopanib Dosing-Response.

Verheijen RB, Huitema AD, Steeghs N.

Clin Cancer Res. 2016 Dec 15;22(24):6299. No abstract available.

22.

Clinical pharmacokinetics of an amorphous solid dispersion tablet of elacridar.

Sawicki E, Verheijen RB, Huitema AD, van Tellingen O, Schellens JH, Nuijen B, Beijnen JH, Steeghs N.

Drug Deliv Transl Res. 2017 Feb;7(1):125-131. doi: 10.1007/s13346-016-0346-3.

PMID:
27864786
23.

Hysteroscopic Resection of a Placental Site Trophoblastic Nodule With a Hysteroscopic Tissue Removal System.

Veersema S, Schreuder H, Verheijen R.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S142. doi: 10.1016/j.jmig.2015.08.490. Epub 2015 Oct 15. No abstract available.

PMID:
27678782
24.

Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.

Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ.

Int J Cancer. 2017 Jan 15;140(2):423-430. doi: 10.1002/ijc.30449. Epub 2016 Oct 11.

25.

Vaginal Radical Trachelectomy for Early-Stage Cervical Cancer: Increased Recurrence Risk for Adenocarcinoma.

Zusterzeel PL, Pol FJ, van Ham M, Zweemer RP, Bekkers RL, Massuger LF, Verheijen RH.

Int J Gynecol Cancer. 2016 Sep;26(7):1293-9. doi: 10.1097/IGC.0000000000000763.

PMID:
27643652
26.

Individualized Pazopanib Dosing: A Prospective Feasibility Study in Cancer Patients.

Verheijen RB, Bins S, Mathijssen RH, Lolkema MP, van Doorn L, Schellens JH, Beijnen JH, Langenberg MH, Huitema AD, Steeghs N; Dutch Pharmacology Oncology Group.

Clin Cancer Res. 2016 Dec 1;22(23):5738-5746. Epub 2016 Jul 28.

27.

Surgical lymph node assessment in mucinous ovarian carcinoma staging: a systematic review and meta-analysis.

Hoogendam JP, Vlek CA, Witteveen PO, Verheijen R, Zweemer RP.

BJOG. 2017 Feb;124(3):370-378. doi: 10.1111/1471-0528.14226. Epub 2016 Jul 22. Review.

28.

Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients.

Farag S, Verheijen RB, Martijn Kerst J, Cats A, Huitema AD, Steeghs N.

Clin Pharmacokinet. 2017 Mar;56(3):287-292. doi: 10.1007/s40262-016-0439-7.

PMID:
27435281
29.

Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.

Uijterwaal MH, van Zummeren M, Kocken M, Luttmer R, Berkhof J, Witte BI, van Baal WM, Graziosi GCM, Verheijen RHM, Helmerhorst TJM, van Dijken DKE, Spruijt JWM, van Kemenade FJ, Fransen-Daalmeijer N, Bekker-Lettink M, Heideman DAM, Snijders PJF, Steenbergen RDM, Meijer CJLM.

Gynecol Oncol. 2016 Oct;143(1):135-142. doi: 10.1016/j.ygyno.2016.07.089. Epub 2016 Jul 16.

PMID:
27430395
30.

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.

Luttmer R, De Strooper LM, Dijkstra MG, Berkhof J, Snijders PJ, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, van Baal WM, Graziosi PG, Quint WG, Spruijt JW, van Dijken DK, Heideman DA, Meijer CJ.

Br J Cancer. 2016 Aug 23;115(5):579-87. doi: 10.1038/bjc.2016.200. Epub 2016 Jul 14.

31.

High-resolution T2-weighted cervical cancer imaging: a feasibility study on ultra-high-field 7.0-T MRI with an endorectal monopole antenna.

Hoogendam JP, Kalleveen IM, de Castro CS, Raaijmakers AJ, Verheijen RH, van den Bosch MA, Klomp DW, Zweemer RP, Veldhuis WB.

Eur Radiol. 2017 Mar;27(3):938-945. doi: 10.1007/s00330-016-4419-y. Epub 2016 May 31.

32.

Diagnosis and management of hydatidiform mole and its complications: 2000 years of a medical challenge.

Jauniaux E, Verheijen R.

BJOG. 2016 Jun;123(7):1183. doi: 10.1111/1471-0528.13940. No abstract available.

33.

p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population.

Luttmer R, Dijkstra MG, Snijders PJ, Berkhof J, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, van Baal WM, Graziosi PG, Quint WG, Spruijt JW, van Dijken DK, Heideman DA, Meijer CJ.

Mod Pathol. 2016 Aug;29(8):870-8. doi: 10.1038/modpathol.2016.80. Epub 2016 May 6.

34.

Screening to improve ovarian cancer prognosis?

Verheijen RHM, Zweemer RP.

Lancet. 2016 Mar 5;387(10022):921-923. doi: 10.1016/S0140-6736(15)01236-2. Epub 2015 Dec 17. No abstract available.

PMID:
26707055
35.

99mTc-Nanocolloid SPECT/MRI Fusion for the Selective Assessment of Nonenlarged Sentinel Lymph Nodes in Patients with Early-Stage Cervical Cancer.

Hoogendam JP, Zweemer RP, Hobbelink MG, van den Bosch MA, Verheijen RH, Veldhuis WB.

J Nucl Med. 2016 Apr;57(4):551-6. doi: 10.2967/jnumed.115.164780. Epub 2015 Dec 17.

36.

Development and clinical validation of an LC-MS/MS method for the quantification of pazopanib in DBS.

Verheijen RB, Bins S, Thijssen B, Rosing H, Nan L, Schellens JH, Mathijssen RH, Lolkema MP, Beijnen JH, Steeghs N, Huitema AD.

Bioanalysis. 2016;8(2):123-34. doi: 10.4155/bio.15.235. Epub 2015 Dec 10.

PMID:
26652864
37.

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.

Sölétormos G, Duffy MJ, Othman Abu Hassan S, Verheijen RH, Tholander B, Bast RC Jr, Gaarenstroom KN, Sturgeon CM, Bonfrer JM, Petersen PH, Troonen H, CarloTorre G, Kanty Kulpa J, Tuxen MK, Molina R.

Int J Gynecol Cancer. 2016 Jan;26(1):43-51. doi: 10.1097/IGC.0000000000000586.

38.

The performance of Dynamic Spectral Imaging colposcopy depends on indication for referrals.

Louwers JA, Zaal A, Kocken M, Berkhof J, Papagiannakis E, Snijders PJ, Meijer CJ, Verheijen RH.

Gynecol Oncol. 2015 Dec;139(3):452-7. doi: 10.1016/j.ygyno.2015.10.009. Epub 2015 Oct 22.

PMID:
26475960
39.

Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).

Luttmer R, De Strooper LM, Berkhof J, Snijders PJ, Dijkstra MG, Uijterwaal MH, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, Van Baal WM, Graziosi PG, Quint WG, Heideman DA, Meijer CJ.

Int J Cancer. 2016 Feb 15;138(4):992-1002. doi: 10.1002/ijc.29824. Epub 2015 Sep 14.

40.

The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.

van der Aa JE, Hoogendam JP, Butter ES, Ausems MG, Verheijen RH, Zweemer RP.

Fam Cancer. 2015 Dec;14(4):539-44. doi: 10.1007/s10689-015-9827-7.

41.

No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients.

Hoogendam JP, Zweemer RP, Verkooijen HM, de Jong PA, van den Bosch MA, Verheijen RH, Veldhuis WB.

PLoS One. 2015 Jul 2;10(7):e0131899. doi: 10.1371/journal.pone.0131899. eCollection 2015.

42.

The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy.

van der Marel J, Rodriguez A, Del Pino M, van Baars R, Jenkins D, van de Sandt MM, Torné A, Ordi J, ter Harmsel B, Verheijen RH, Schiffman M, Gage JC, Quint WG, Wentzensen N.

J Low Genit Tract Dis. 2015 Oct;19(4):282-7. doi: 10.1097/LGT.0000000000000124.

PMID:
26083332
43.

The diagnostic process of cervical cancer; areas of good practice, and windows of opportunity.

Zaal A, de Wilde MA, Duk MJ, Graziosi GC, van Haaften M, von Mensdorff-Pouilly S, van Diest PJ, Zweemer RP, Peeters PH, Verheijen RH.

Gynecol Oncol. 2015 Aug;138(2):405-10. doi: 10.1016/j.ygyno.2015.05.037. Epub 2015 May 30.

PMID:
26037902
44.

99mTc SPECT/CT Versus Planar Lymphoscintigraphy for Preoperative Sentinel Lymph Node Detection in Cervical Cancer: A Systematic Review and Metaanalysis.

Hoogendam JP, Veldhuis WB, Hobbelink MG, Verheijen RH, van den Bosch MA, Zweemer RP.

J Nucl Med. 2015 May;56(5):675-80. doi: 10.2967/jnumed.114.152439. Epub 2015 Apr 9. Review.

45.

Does probability guided hysteroscopy reduce costs in women investigated for postmenopausal bleeding?

Breijer MC, van Hanegem N, Visser NC, Verheijen RH, Mol BW, Pijnenborg JM, Opmeer BC, Timmermans A.

ScientificWorldJournal. 2015;2015:605312. doi: 10.1155/2015/605312. Epub 2015 Feb 16.

46.

The work place educational climate in gynecological oncology fellowships across Europe: the impact of accreditation.

Piek J, Bossart M, Boor K, Halaska M, Haidopoulos D, Zapardiel I, Grabowski J, Kesic V, Cibula D, Colombo N, Verheijen R, Manchanda R.

Int J Gynecol Cancer. 2015 Jan;25(1):180-90. doi: 10.1097/IGC.0000000000000323.

PMID:
25525769
47.

Women's Preferences of Dynamic Spectral Imaging Colposcopy.

Louwers JA, Zaal A, Kocken M, Papagiannakis E, Meijer CJ, Verheijen RH.

Gynecol Obstet Invest. 2015;79(4):239-43. doi: 10.1159/000367921. Epub 2014 Nov 19.

PMID:
25413738
48.

Notch signaling in serous ovarian cancer.

Groeneweg JW, Foster R, Growdon WB, Verheijen RH, Rueda BR.

J Ovarian Res. 2014 Nov 4;7:95. doi: 10.1186/s13048-014-0095-1. Review.

49.

The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.

van der Marel J, van Baars R, Rodriguez A, Quint WG, van de Sandt MM, Berkhof J, Schiffman M, Torné A, Ordi J, Jenkins D, Verheijen RH, Helmerhorst TJ, Ter Harmsel B, Wentzensen N, Del Pino M.

Gynecol Oncol. 2014 Nov;135(2):201-7. doi: 10.1016/j.ygyno.2014.08.040. Epub 2014 Sep 7.

PMID:
25204846
50.

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

Skinner SR, Szarewski A, Romanowski B, Garland SM, Lazcano-Ponce E, Salmerón J, Del Rosario-Raymundo MR, Verheijen RH, Quek SC, da Silva DP, Kitchener H, Fong KL, Bouchard C, Money DM, Ilancheran A, Cruickshank ME, Levin MJ, Chatterjee A, Stapleton JT, Martens M, Quint W, David MP, Meric D, Hardt K, Descamps D, Geeraerts B, Struyf F, Dubin G; VIVIANE Study Group.

Lancet. 2014 Dec 20;384(9961):2213-27. doi: 10.1016/S0140-6736(14)60920-X. Epub 2014 Sep 1.

PMID:
25189358

Supplemental Content

Loading ...
Support Center